Comerica Bank
VNDA icon

Comerica Bank’s Vanda Pharmaceuticals VNDA Stock Holding History

Comerica Bank’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-503
Closed -$2.41K – 3767
2024
Q4 		$2.41K Sell
503
-504
-50% -$2.42K ﹤0.01% 3454
2024
Q3 		$4.72K Hold
1,007
– – ﹤0.01% 3348
2024
Q2 		$5.69K Hold
1,007
– – ﹤0.01% 3279
2024
Q1 		$4.14K Sell
1,007
-25
-2% -$100 ﹤0.01% 3373
2023
Q4 		$4.36K Hold
1,032
– – ﹤0.01% 3358
2023
Q3 		$4.46K Buy
1,032
+198
+24% +$1.1K ﹤0.01% 3391
2023
Q2 		$75 Buy
+834
New +$5.35K 0.01% 137
2022
Q4 		$258K Sell
33,847
-9,509
-22% -$92.6K ﹤0.01% 1997
2022
Q3 		$450K Sell
43,356
-4,715
-10% -$49.8K ﹤0.01% 1817
2022
Q2 		$555K Buy
48,071
+365
+0.8% +$3.78K ﹤0.01% 1789
2022
Q1 		$537K Buy
47,706
+1,180
+3% +$15.5K ﹤0.01% 1841
2021
Q4 		$682K Sell
46,526
-55,941
-55% -$975K 0.01% 1739
2021
Q3 		$1.72M Buy
102,467
+50,469
+97% +$884K 0.01% 1396
2021
Q2 		$798K Sell
51,998
-3,400
-6% -$60.8K ﹤0.01% 1828
2021
Q1 		$940K Sell
55,398
-2,155
-4% -$34.9K 0.01% 1780
2020
Q4 		$817K Buy
57,553
+497
+0.9% +$5.98K 0.01% 1824
2020
Q3 		$585K Sell
57,056
-51
-0.1% -$545 ﹤0.01% 1836
2020
Q2 		$621K Buy
57,107
+5,424
+10% +$61.4K ﹤0.01% 1769
2020
Q1 		$617K Buy
51,683
+1,609
+3% +$19.9K 0.01% 1628
2019
Q4 		$651K Buy
50,074
+65
+0.1% +$983 ﹤0.01% 1778
2019
Q3 		$686K Buy
50,009
+405
+0.8% +$5.64K 0.01% 1733
2019
Q2 		$659K Sell
49,604
-2,238
-4% -$35.6K 0.01% 1753
2019
Q1 		$928K Buy
51,842
+725
+1% +$16.5K 0.01% 1617
2018
Q4 		$1.46M Buy
+51,117
New +$1.2M 0.01% 1315

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Comerica Bank's VNDA Position: Q1 2025 in Review

Comerica Bank sold out of Vanda Pharmaceuticals (VNDA) in Q1 2025, closing a stake of 503 shares — an estimated $2.41K sold.

Comerica Bank first reported a position in VNDA in Q4 2018 and held it in 24 quarters. The position peaked at $1.72M in Q3 2021. 146 funds tracked by Wall St. Rank hold VNDA as of Q1 2025.

  • Comerica Bank reported no remaining Vanda Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Comerica Bank sold 503 Vanda Pharmaceuticals shares in Q1 2025, an estimated $2.41K.
  • Comerica Bank first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 24 quarters.
  • Comerica Bank's Vanda Pharmaceuticals position peaked at $1.72M in Q3 2021.
  • 146 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2025.

Based on Comerica Bank's 13F filing for Q1 2025, filed 14 May 2025.